FDA approves novel device to treat insomnia

A new medical device approved by the Food and Drug Administration (FDA) offers the 55 million Americans who suffer from insomnia a drug-free alternative to help them fall back to sleep. The Cerêve Sleep System is a prescription device that is clinically proven to reduce latency to Stage 1 and Stage 2 sleep for people with insomnia. The inspiration behind the Cerêve Sleep System came from pioneering functional brain imaging studies conducted by Eric Nofzinger, MD, a board certified sleep physician and the company’s founder, at the University of Pittsburgh. Patients with insomnia often describe “racing minds” that prevent them ... Read More